RecruitingNot ApplicableNCT07598227

Moxibustion for Nocturia

Evaluation of the Efficacy and Safety of Acupoint Moxibustion for Nocturia: A Pilot Study


Sponsor

Buddhist Tzu Chi General Hospital

Enrollment

100 participants

Start Date

Jan 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Nocturia, the interruption of sleep due to nighttime voiding, severely compromises quality of life, emotional health, and overall well-being when occurring twice or more per night. Given that some patients experience inadequate responses to conventional Western therapies or harbor concerns about the long-term side effects of pharmaceuticals, many are turning to Traditional Chinese Medicine (TCM) for alternative solutions. This study utilized a randomized clinical trial design to investigate the efficacy and safety of acupoint moxibustion for nocturia.


Eligibility

Min Age: 40 Years

Inclusion Criteria2

  • Patients aged 40 years or older.
  • Experiencing two or more nocturia episodes per night.

Exclusion Criteria6

  • Active urinary tract infection (UTI).
  • Poorly controlled diabetes mellitus (defined as HbA1c > 6.5%).
  • Presence of a neurogenic bladder caused by conditions such as multiple sclerosis, Parkinson's disease, stroke, spinal cord injury, or nerve damage resulting from major pelvic surgery.
  • Severe congestive heart failure (New York Heart Association \[NYHA\] functional class > II).
  • Use of other Traditional Chinese Medicine (TCM) therapies for nocturia symptoms within the past month (30 days).
  • Pregnant women.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREMoxibustion

Apply moxibustion on acupoint


Locations(1)

Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation

Hualien City, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07598227


Related Trials